Spearhead Investments (Bio) Ltd.

Formerly Cure Investments

Investment Company

Tech Verticals Preferences

Biomed, Digital Health, Medical Cannabis, Medical Devices

General Data

Established	2007
Current Active Portfolio Companies:	5
Reg. Number:	abCDe

DESCRIPTION

Spearhead Investments is a wholly owned subsidiary of Biomedix, a holding company controlling the Meytav and Ashkelon (ATI) Incubators. Spearhead is dedicated to investments in life sciences companies that graduated from the two aforementioned incubators. Spearhead will also seek investments in other life sciences companies and incubators.

REMARKS

Date	Remark
	Spearhead (through Biomedix) signed an agreement with Pontifax according to which Pontifax will invest 20%, or up to $1m, of every invetsment by Spearhead. Both Biomedix and Pontifax will not invest in these companies outside Spearhead.

CONTACT INFO

Expand / Collapse All

Main Address: Ramat Gan, Israel

Address	7 Jabotinski St., Moshe Aviv Tower
City	Ramat Gan
Country	Israel
Zip	5252007

Contact Person	abC Defghij
Contact E-Mail	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

	MANAGEMENT

Key Executive

Name	Title	Previous Position
Mr. Tomer Kariv	Chairman	Biomedix (Director)

	FINANCIAL ROUNDS

Expand / Collapse All

Round

Date

Stage

Amount

Valuation

Other

Oct. 11, 2011

abCDe

Other

Jun. 01, 2008

abCDe

Venture Lending

Jun. 21, 2007

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Holding Company	abCDe	Loan

Other

Jan. 01, 2007

abCDe

Preferences

Type of Financing	Equity
Stage Preferences	R&D,Seed
Phase Preferences	Clinical Trials,Discovery,Phase I,Phase II,Phase III,Pre Clinical

SECTOR SEGMENTATION (By Number Of Companies)

Biomed

50%

Medical Devices

50%

	PORTFOLIO COMPANIES

Current Portfolio Companies (5)

Company Name

Sector

Round/Deal Type

Date Announced

Investor Amount

Total Deal Amount

Remarks

Allmed Solutions

PIPE

10/03/2010

N/A

$2.1m

Holds 18.18% of the company

Check-Cap

Fourth Round

19/02/2015

N/A

$12m

CollPlant

Biomed

Third Round

03/04/2008

N/A

$8.35m

Holds 11.7% of the company

SciSparc

Biomed

PIPE

01/10/2007

N/A

VVT

VVT Med develops, manufactures, and commercializes minimally invasive, non-thermal, and non-tumescent solutions for the treatment of varicose veins. VVT Med's products offer several key competitive advantages over traditional alternatives, including faster treatment times, reduced pain without the need for anesthesia, and quicker recovery and results.

Seed

21/08/2007

$0.45m

$0.9m

Holds 25% of the company

Exits (2)

Company Name	Exit Type	Date Announced	Amount	Remarks
abC Defghij	IPO	19/02/2015	abCDe	In addition, $12m were raised in a simultaneous private placement of the same securities.
abC Defghij	Acquired	11/09/2011	abCDe	A share-swap deal.

Historic Portfolio (2)

Company Name

Sector

Round/Deal Type

Date Announced

Investor Amount

Total Deal Amount

Remarks

BioMagnesium

Ceased to Operate

$BioMagnesium developed a magnesium-based resorbable fracture fixation system for orthopedic applications.$

First Round

03/05/2007

N/A

$0.44m

ReLeaf

Suspendeed Operations

Seed - Extended

06/11/2007

N/A

$0.86m

Last Updated:	abCDe
IVC Number:	abCDe